Life Technologies (LIFE +1%) trades higher after receiving FDA clearance for its OpTmizer T-Cell...

|By:, SA News Editor

Life Technologies (LIFE +1%) trades higher after receiving FDA clearance for its OpTmizer T-Cell growth medium for use in clinical trials. The product is designed to efficiently grow large numbers of potentially therapeutic T-cells, which have demonstrated promise in clinical studies as an effective treatment for diseases including cancer, infectious diseases such as AIDS, and autoimmune disorders.